Journal List > J Bacteriol Virol > v.38(1) > 1033915

Kim, Yi, and Lee: Human Cytomegalovirus Induces Intercellular Adhesion Molecule-1 Expression in a Monocytic Cell Line, THP-1

Abstract

It has been reported that inflammatory diseases such as pneumonitis, retinitis, and hepatitis are associated with human cytomegalovirus (HCMV). Intercellular adhesion molecule (ICAM)-1 is an important inflammatory mediator, helping monocytes adhere to endothelial cells when tissues are infected by pathogen including the HCMV. However, little is known about the mechanism of ICAM-1 stimulation by the HCMV infection in monocytes. In this study, a monocytic cell line THP-1 was used to understand ICAM-1 expression by the HCMV infection. Flow cytometric analyses demonstrated that ICAM-1 was stimulated by the HCMV in THP-1 cells with maximum at 24 hours post infection. The stimulated ICAM-1 expression was dependent on the amount of input virus. In order to understand the mechanism of ICAM-1 stimulation during the HCMV infection, cells were treated with specific inhibitors of key elements in inflammation: NF-κB inhibitor PDTC, cyclooxygenase 2 inhibitor NS398, and MEK inhibitor PD98059. Flow cytometric analyses revealed that ICAM-1 expression was decreased when treated with PDTC, but not with NS398 or PD98059. Thus, it is suggested that HCMV-induced ICAM-1 expression in THP-1 cells is associates with NF-κB.

References

1). Bolovan-Fritts CA, Mocarski ES, Wiedeman JA. Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood. 93:394–398. 1999.
crossref
2). Caposio P, Dreano M, Garotta G, Gribaudo G, Landolfo S. Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication. J Virol. 78:3190–3195. 2004.
crossref
3). Chan G, Bivins-Smith ER, Smith MS, Yurochko AD. Transcriptome analysis of NF-kappaB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes. J Virol. 82:1040–1046. 2008.
4). Chan G, Stinski MF, Guilbert LJ. Human cytomegalovirus-induced upregulation of intercellular cell adhesion molecule-1 on vilous syncytiotrophoblasts. Biol Reprod. 71:797–803. 2004.
5). Chen J, Stinski MF. Role of regulatory elements and the MAPK/ERK or p38 MAPK pathways for activation of human cytomegalovirus gene expression. J Virol. 76:4873–4885. 2002.
crossref
6). Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 62:3347–3350. 2002.
7). Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 25:6680–6684. 2006.
8). Grundy JE, Downes KL. Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with Cytomegalovirus. Immunology. 78:405–412. 1993.
9). Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA. 95:3937–3942. 1998.
crossref
10). Ito M, Watanabe M, Ihara T, Kamiya H, Sakurai M. Increased expression of adhesion molecules (CD54, CD29 and CD44) on fibroblasts infected with cytomegalovirus. Microbiol Immunol. 39:129–133. 1995.
crossref
11). Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol. 12:85–98. 2000.
12). Kevil CG, Patel RP, Bullardl DC. Essential role of ICAM-1 in mediating monocyte adhesion to aortic endothelial cells. Am J Physiol Cell Physiol. 281:1442–1447. 2001.
crossref
13). Knight DA, Waldman WJ, Sedmak DD. Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells. Transplantation. 68:1814–1818. 1999.
14). Kondo K, Kaneshima H, Mocarski ES. Human cytomegalo-virus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci USA. 91:11879–11883. 1994.
crossref
15). Matsubara M, Tamura T, Ohmori K, Hasegawa K. Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades. Biochem Pharmacol. 69:433–449. 2005.
16). Mendelson M, Monard S, Sissons P, Sinclair J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol. 77:3099–3102. 1996.
crossref
17). Minton EJ, Tysoe C, Sinclair JH, Sissons JG. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol. 68:4017–4021. 1994.
crossref
18). Mocarski ES Jr, Shenk T, Pass RF. Cytomegalovirus. pp.p. 2701–2772. In. Fields Virology. 5th ed.Knipe DM, Howley PM, editors. (Ed).Lippincott Williams & Wilkins;Philadelphia, USA: 2007.
19). Munro JM. Endothelial-leukocyte adhesive interactions in inflammatory diseases. Eur Heart J. 14:72–77. 1993.
20). Panta GR, Kaur S, Cavin LG, Cortes ML, Mercurio F, Lothstein L, Sweatman TW, Israel M, Arsura M. ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signaling pathway in response to distinct forms of DNA damage. Mol Cell Biol. 24:1823–1835. 2004.
21). Rahbar A, Soderberg-Naucler C. Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol. 79:2211–2220. 2005.
crossref
22). Rodems SM, Spector DH. Extracellular Signal-Regulated Kinase Activity Is Sustained Early during Human Cytomegalo-virus Infection. J Virol. 72:9173–9180. 1998.
crossref
23). Sedmak DD, Knight DA, Vook NC, Waldman JW. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation. 58:1379–1385. 1994.
24). Smith MS, Bentz GL, Smith PM, Bivins ER, Yurochko AD. HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner. J Leukoc Biol. 76:65–76. 2004.
crossref
25). Smith MS, Bivins-Smith ER, Tilley AM, Bentz GL, Chan G, Minard J, Yurochko AD. Roles of phosphatidylinositol 3-kinase and NF-kappaB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence. J Virol. 81:7683–7694. 2007.
26). Söderberg-Nauclér C. HCMV microinfections in inflammatory diseases and cancer. J Clin Virol. 41:218–223. 2008.
crossref
27). Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol. 72:2059–2064. 1991.
crossref
28). Yurochko AD, Kowalik TF, Huong SM, Huang ES. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol. 69:5391–5400. 1995.
crossref
29). Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci USA. 99:3932–3937. 2002.
crossref

Figure 1.
Stimulation of ICAM-1 expression by the HCMV infection on the surface of THP-1 cells. THP-1 cells were infected by HCMV TB40/E at MOI of 1 pfu/cell. Cells were harvested at indicated times and stained with PE-conjugated anti-ICAM-1 antibody. PE fluorescence was determined by a flow cytometry. (A) Flow cytometrogram of a representative experiment. C, background fluorescence; M, mock-infected cells; V, virus-infected cells. (B) Time course of ICAM-1 expression. Data are averages of three or more experiments with error bars. Open circles, mock-infected cells; closed circles, HCMV-infected cells.
jbv-38-39f1.tif
Figure 2.
HCMV MOI-dependent stimulation of ICAM-1 expression. THP-1 cells were infected with HCMV TB40/E at different MOIs. Cells were harvested at 24 hours post infection. Cells were stained with PE-conjugated anti-ICAM-1 antibody and analyzed by a flow cytometry. (A) Flow cytometrogram. C, background fluorescence; V, virus-infected cells. (B) Relative ICAM-1 expression.
jbv-38-39f2.tif
Figure 3.
Effect of specific inhibitors on the HCMV-induced ICAM-1 expression. Cells were pre-treated with inhibitors for 30 minutes and infected with HCMV TB40/E at 1 MOI. Twenty four hours after infection, cells were harvested, fixed and stained with PE-conjugated anti-ICAM-1 antibody and fluorescence was determined by a flow cytometry. (A) treated with NF-κB inhibtor PDTC (1 μM); (B) treated with COX-2 inhibitor NS398 (50 μM); (C) treated with MEK inhibtor PD98059 (50 μM).
jbv-38-39f3.tif
Figure 4.
HCMV does not stimulate COX-2 expression or ERK1/2 phosphorylation in THP-1 cells. THP-1 or HFF cells were infected with HCMV (strain TB40/E, MOI = 1). At indicated times after virus infection, cells were harvested and subjected to western blot analysis. (A) COX-2; (B) ERK1/2.
jbv-38-39f4.tif
TOOLS
Similar articles